Mateo, thanks for the insight. This is not the first stock I have seen retreat even after pretty good news. This news makes me a lot more confident. I remember PBT had a "to market" facility in place where the broker was only permitted to sell on an uptick. Not sure if that applies here. You could be right about ATH selling into the rise. You are right about the efficacy seen in animal models now manifesting in human subjects. Now here is ATH434 demonstrating efficacy in the human 202 open label trial. Now for the first time I think there is a genuine MSA drug candidate. That is a possible blockbuster market on its own.
What to hopefully look forward too, page-15
-
- There are more pages in this discussion • 15 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ATH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.4¢ |
Change
0.001(33.3%) |
Mkt cap ! $21.28M | |||
| Open | High | Low | Value | Volume |
| 0.3¢ | 0.4¢ | 0.3¢ | $5.491K | 1.520M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 39 | 50987030 | 0.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.4¢ | 126437200 | 27 |
View Market Depth
| Last trade - 16.10pm 27/08/2024 (20 minute delay) ? |
| ATH (ASX) Chart |